Mostrar el registro sencillo del ítem

dc.contributor.authorAlonso García, Isaac*
dc.contributor.authorVázquez Ucha, Juan Carlos*
dc.contributor.authorMartínez Guitian, Marta*
dc.contributor.authorLasarte Monterrubio, Cristina*
dc.contributor.authorRodríguez Pallares, Salud*
dc.contributor.authorCamacho Zamora, Pablo*
dc.contributor.authorRumbo Feal, Soraya*
dc.contributor.authorAja Macaya, Pablo*
dc.contributor.authorGonzález Pinto, Lucía*
dc.contributor.authorOuteda García, Michelle*
dc.contributor.authorMaceiras Senande, Romina Lucía*
dc.contributor.authorGuijarro Sanchez, Paula*
dc.contributor.authorMuiño Andrade, María José*
dc.contributor.authorFernández González, Ana*
dc.contributor.authorOviaño García, Marina *
dc.contributor.authorGonzález-Bello, C.*
dc.contributor.authorArca Suárez, Jorge*
dc.contributor.authorBeceiro Casas, Alejandro*
dc.contributor.authorBou Arévalo, Germán *
dc.date.accessioned2025-09-10T08:38:15Z
dc.date.available2025-09-10T08:38:15Z
dc.date.issued2023
dc.identifier.citationAlonso-García I, Vázquez-Ucha JC, Martínez-Guitián M, Lasarte-Monterrubio C, Rodríguez-Pallares S, Camacho-Zamora P, et al. Interplay between OXA-10 ?-Lactamase Production and Low Outer-Membrane Permeability in Carbapenem Resistance in Enterobacterales. Antibiotics. 2023;12(6).
dc.identifier.issn2079-6382
dc.identifier.otherhttps://portalcientifico.sergas.gal//documentos/64b4ef6d2107cd1e6d71d0c1
dc.identifier.urihttp://hdl.handle.net/20.500.11940/21658
dc.description.abstractThe OXA-10 class D ?-lactamase has been reported to contribute to carbapenem resistance in non-fermenting Gram-negative bacilli; however, its contribution to carbapenem resistance in Enterobacterales is unknown. In this work, minimum inhibitory concentrations (MICs), whole genome sequencing (WGS), cloning experiments, kinetic assays, molecular modelling studies, and biochemical assays for carbapenemase detection were performed to determine the impact of OXA-10 production on carbapenem resistance in two XDR clinical isolates of Escherichia coli with the carbapenem resistance phenotype (ertapenem resistance). WGS identified the two clinical isolates as belonging to ST57 in close genomic proximity to each other. Additionally, the presence of the blaOXA-10 gene was identified in both isolates, as well as relevant mutations in the genes coding for the OmpC and OmpF porins. Cloning of blaOXA-10 in an E. coli HB4 (OmpC and OmpF-deficient) demonstrated the important contribution of OXA-10 to increased carbapenem MICs when associated with porin deficiency. Kinetic analysis showed that OXA-10 has low carbapenem-hydrolysing activity, but molecular models revealed interactions of this ?-lactamase with the carbapenems. OXA-10 was not detected with biochemical tests used in clinical laboratories. In conclusion, the ?-lactamase OXA-10 limits the activity of carbapenems in Enterobacterales when combined with low permeability and should be monitored in the future.
dc.description.sponsorshipThis work was supported by Projects PI20/01212 awarded to A.B., Project PI18/00501 awarded to G.B., and Project PI22/01212 awarded to J.A.-S. within in the National Plan for Scientific Research, Development and Technological Innovation 2017-2020 funded by the Instituto de Salud Carlos III (ISCIII)-General Subdirection of Assessment and Promotion of the Research-European Regional Development Fund (FEDER) A way of making Europe. The work was also supported by CIBER-Consorcio Centro de Investigacion Biomedica en Red- de Enfermedades Infecciosas, Instituto de Salud Carlos III (CB21/13/00055), Ministerio de Ciencia e Innovacion and Union Europea-NextGenerationEU and by project IN607A 2020/05 (GAIN-Agencia Gallega de Innovacion-Conselleria de Economia, Emprego e Industria) awarded to G.B. and project IN607D 2021/12 awarded to A.B. JA-S was financially supported by the Juan Rodes program (ISCIII, JR21/00026), J.C.V.-U. was financially supported by IN606B-2022/009 (Xunta de Galicia), C.L.-M. was financially supported by IN606A-2019/029 Grant (Xunta de Galicia) and PI20/01212 (ISCIII), P.G.-S. was financially supported by IN606A 2021/021 Grant (Xunta de Galicia). M.O.-G. was financially supported by IN607D 2021/12. I.A.-G. was financially supported by the Rio Hortega program (ISCIII, CM21/00076). M.M.-G. was financially supported by RSU.UDC.M505 (Ministerio de Universidades). C.G.-B acknowledges financial support from the Spanish Ministry of Science and Innovation (PID2019-105512RB-I00/AEI/10.13039/501100011033), the Xunta de Galicia [ED431C 2021/29 and the Centro singular de investigacion de Galicia accreditation 2019-2022 (ED431G 2019/03)], and the European Regional Development Fund (ERDF).
dc.languageeng
dc.rightsAttribution 4.0 International (CC BY 4.0)*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleInterplay between OXA-10 ?-Lactamase Production and Low Outer-Membrane Permeability in Carbapenem Resistance in Enterobacterales
dc.typeArtigo
dc.authorsophosAlonso-García, I.; Vázquez-Ucha, J.C.; Martínez-Guitián, M.; Lasarte-Monterrubio, C.; Rodríguez-Pallares, S.; Camacho-Zamora, P.; Rumbo-Feal, S.; Aja-Macaya, P.; González-Pinto, L.; Outeda-García, M.; Maceiras, R.; Guijarro-Sánchez, P.; Muíño-Andrade, M.J.; Fernández-González, A.; Oviaño, M.; González-Bello, C.; Arca-Suárez, J.; Beceiro, A.; Bou, G.
dc.identifier.doi10.3390/antibiotics12060999
dc.identifier.sophos64b4ef6d2107cd1e6d71d0c1
dc.issue.number6
dc.journal.titleAntibiotics*
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Microbioloxía
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Unidade de investigación
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Biomédica de A Coruña (INIBIC)
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Biomédica de A Coruña (INIBIC)::Unidade de investigación
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Microbioloxía
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Pontevedra::Microbioloxía
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Microbioloxía
dc.organizationInstituto de Investigación Biomédica de A Coruña (INIBIC)
dc.organizationComplexo Hospitalario Universitario A Coruña
dc.organizationInstituto de Investigación Biomédica de A Coruña (INIBIC)
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Microbioloxía
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Biomédica de A Coruña (INIBIC)::Unidade de investigación
dc.organizationComplexo Hospitalario Universitario A Coruña
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Biomédica de A Coruña (INIBIC)::Microbioloxía
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Microbioloxía
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Unidade de investigación
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Microbioloxía
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Microbioloxía
dc.relation.projectIDNational Plan for Scientific Research, Development and Technological Innovation - Instituto de Salud Carlos III (ISCIII)-General Subdirection of Assessment and Promotion of the Research-European Regional Development Fund (FEDER) A way of making Europe
dc.relation.projectIDCIBER-Consorcio Centro de Investigacion Biomedica en Red- de Enfermedades Infecciosas, Instituto de Salud Carlos III [PI20/01212, PI18/00501, PI22/01212]
dc.relation.projectIDMinisterio de Ciencia e Innovacion and Union Europea-NextGenerationEU [CB21/13/00055]
dc.relation.projectIDGAIN-Agencia Gallega de Innovacion-Conselleria de Economia, Emprego e Industria
dc.relation.projectIDJuan Rodes program (ISCIII) [IN607A 2020/05, IN607D 2021/12]
dc.relation.projectIDXunta de Galicia [JR21/00026]
dc.relation.projectIDRio Hortega program (ISCIII) [IN606B-2022/009, IN606A-2019/029, IN606A 2021/021, PID2019-105512RB-I00]
dc.relation.projectIDMinisterio de Universidades [ED431C 2021/29]
dc.relation.projectIDSpanish Ministry of Science and Innovation [CM21/00076]
dc.relation.projectIDCentro singular de investigacion de Galicia [RSU.UDC.M505]
dc.relation.projectIDEuropean Regional Development Fund (ERDF) [ED431G 2019/03]
dc.relation.publisherversionhttps://doi.org/10.3390/antibiotics12060999
dc.rights.accessRightsopenAccess*
dc.subject.keywordAS A Coruña
dc.subject.keywordCHUAC
dc.subject.keywordAS A Coruña
dc.subject.keywordCHUAC
dc.subject.keywordAS A Coruña
dc.subject.keywordINIBIC
dc.subject.keywordAS A Coruña
dc.subject.keywordINIBIC
dc.subject.keywordAS A Coruña
dc.subject.keywordCHUAC
dc.subject.keywordAS Pontevedra
dc.subject.keywordCHUP
dc.subject.keywordAS A Coruña
dc.subject.keywordCHUAC
dc.subject.keywordINIBIC
dc.subject.keywordCHUAC
dc.subject.keywordINIBIC
dc.subject.keywordAS A Coruña
dc.subject.keywordCHUAC
dc.subject.keywordAS A Coruña
dc.subject.keywordINIBIC
dc.subject.keywordCHUAC
dc.subject.keywordAS A Coruña
dc.subject.keywordINIBIC
dc.subject.keywordAS A Coruña
dc.subject.keywordCHUAC
dc.subject.keywordAS A Coruña
dc.subject.keywordCHUAC
dc.subject.keywordAS A Coruña
dc.subject.keywordCHUAC
dc.subject.keywordAS A Coruña
dc.subject.keywordCHUAC
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)
dc.typesophosArtículo Original
dc.volume.number12


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution 4.0 International (CC BY 4.0)
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International (CC BY 4.0)